Publications by authors named "Pragathi Devanand Bangera"

Claim this Profile
B
Biohybrid nanocarriers for targeted drug delivery by integrating biological interfaces with synthetic platforms for site-specific therapeutics.
Sathvik Chennamsetty, Mahesha Keerikkadu, Akshay Shetty, Pragathi Devanand Bangera, Vamshi Krishna Tippavajhala

Int J Pharm· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative green synthesis and molecular simulation of ibrutinib cocrystals for enhanced biopharmaceutical performance and in vivo pharmacokinetics.
Divya Dhatri Kara, Pragathi Devanand Bangera, Mahesha Keerikkadu, Mahalaxmi Rathnanand

Int J Pharm X· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced nanoparticle-enabled risperidone delivery for improved therapeutic outcomes of schizophrenia management: a review.
Ashwin Kumar, Mahesha Keerikkadu, Pragathi Devanand Bangera, Akshay Shetty, Vamshi Krishna Tippavajhala

Drug Dev Ind Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of advanced nanocarrier systems for Ibrutinib delivery: overcoming pharmacokinetic barriers and enabling targeted cancer therapy.
Akshay Shetty, Mahesha Keerikkadu, Pragathi Devanand Bangera, Vamshi Krishna Tippavajhala, Mahalaxmi Rathnanand

Int J Pharm X· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional Engineering of Exosomes for Precision Therapeutics: Strategies for Targeted Delivery, Barrier Evasion, and Clinical Translation.
Shea Riona Mendonca, Pragathi Devanand Bangera, Mahesha Keerikkadu, Vamshi Krishna Tippavajhala, Mahalaxmi Rathnanand

Pharm Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Overview on Lipid Nanocapsules: Exploring the Role in Precision Cancer Treatment and Lymphatic Drug Distribution.
Mahesha Keerikkadu, Pragathi Devanand Bangera, Vamshi Krishna Tippavajhala, Mahalaxmi Rathnanand

Adv Pharm Bull· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib Pharmacokinetics and Advanced Nanocarrier Strategies: from Systemic Limitations to Targeted Success.
Mahesha Keerikkadu, Pragathi Devanand Bangera, Vamshi Krishna Tippavajhala, Mahalaxmi Rathnanand

AAPS PharmSciTech· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation and evaluation of ibrutinib-loaded glycyrrhizic acid conjugated ovalbumin nanoparticles and ibrutinib-glycyrrhizic acid complex for improved oral bioavailability.
Prateeksha Prakash Kamath, Pragathi Devanand Bangera, Divya Dhatri Kara, Rajeshwari Roychowdhury, Vamshi Krishna Tippavajhala

Pharm Dev Technol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Silico Screening as a Tool to Prepare Drug-Drug Cocrystals of Ibrutinib-Ketoconazole: a Strategy to Enhance Their Solubility Profiles and Oral Bioavailability.
Divya Dhatri Kara, Pragathi Devanand Bangera, Chetan Hasmukh Mehta, Katikala Tanvi, Mahalaxmi Rathnanand

AAPS PharmSciTech· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights on Cell-Penetrating Peptides and Polymer-Lipid Hybrid Nanoparticle: Overview and Therapeutic Applications for Targeted Anticancer Therapy.
Pragathi Devanand Bangera, Divya Dhatri Kara, Katikala Tanvi, Vamshi Krishna Tippavajhala, Mahalaxmi Rathnanand

AAPS PharmSciTech· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis